Cargando…

Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma

SIMPLE SUMMARY: This study was designed to investigate the potential for targeting the NF-κB-inducing kinase, NIK, in two common B-cell malignancies, chronic lymphocytic leukemia (CLL) and multiple myeloma (MM). Using a selective NIK inhibitor, CW15337, we were able to demonstrate that cell lines an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burley, Thomas A., Kennedy, Emma, Broad, Georgia, Boyd, Melanie, Li, David, Woo, Timothy, West, Christopher, Ladikou, Eleni E., Ashworth, Iona, Fegan, Christopher, Johnston, Rosalynd, Mitchell, Simon, Mackay, Simon P., Pepper, Andrea G. S., Pepper, Chris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946537/ https://www.ncbi.nlm.nih.gov/pubmed/35326640 http://dx.doi.org/10.3390/cancers14061489

Ejemplares similares

Elucidation of Focal Adhesion Kinase as a Modulator of Migration and Invasion and as a Potential Therapeutic Target in Chronic Lymphocytic Leukemia
por: Burley, Thomas A., et al.
Publicado: (2022)

PB1788: LOW EXPRESSION OF C-TYPE LECTIN-LIKE MOLECULE-1 AND REDUCED OXIDATIVE STRESS DEFINE A SUBSET OF ACUTE MYELOID LEUKAEMIA CELLS WITH ‘STEM-LIKE’ PROPERTIES
por: Sharp, K., et al.
Publicado: (2022)

Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
por: Paul, Andrew, et al.
Publicado: (2018)

NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma
por: Jayawant, Eleanor, et al.
Publicado: (2023)

Regulation of Bcl-XL by non-canonical NF-κB in the context of CD40-induced drug resistance in CLL
por: Haselager, Marco, et al.
Publicado: (2021)

The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-κB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells
por: Walsby, Elisabeth, et al.
Publicado: (2012)

NF-kB and the CLL microenvironment
por: O’Donnell, Alice, et al.
Publicado: (2023)

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)

Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling
por: Mulligan, Evan A., et al.
Publicado: (2023)

Novel pyrrolobenzodiazepine benzofused hybrid molecules inhibit nuclear factor-κB activity and synergize with bortezomib and ibrutinib in hematologic cancers
por: Lewis, Thomas, et al.
Publicado: (2020)

Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway
por: Yang, Li, et al.
Publicado: (2018)

Bacterial interference with canonical NFκB signalling
por: Johannessen, Mona, et al.
Publicado: (2013)

Clinical benefit of ixazomib plus lenalidomide‐dexamethasone in myeloma patients with non‐canonical NF‐κB pathway activation
por: Dash, Ajeeta B., et al.
Publicado: (2020)

Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway
por: Roy, P, et al.
Publicado: (2017)

IKKα plays a major role in canonical NF-κB signalling in colorectal cells
por: Prescott, Jack A., et al.
Publicado: (2022)

Canonical and Non-Canonical NF-κB Signaling Promotes Breast Cancer Tumor-Initiating Cells
por: Kendellen, Megan F., et al.
Publicado: (2013)

The NF-κB Activating Pathways in Multiple Myeloma
por: Roy, Payel, et al.
Publicado: (2018)

Targeting NF-κB Signaling for Multiple Myeloma
por: Wong, Ada Hang-Heng, et al.
Publicado: (2020)

Non-canonical NFκB activation promotes chemokine expression in podocytes
por: Valiño-Rivas, Lara, et al.
Publicado: (2016)

Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth
por: Achyut, B. R., et al.
Publicado: (2017)

Manipulation of Non-canonical NF-κB Signaling by Non-oncogenic Viruses
por: Struzik, Justyna, et al.
Publicado: (2018)

Differential recognition of canonical NF-κB dimers by Importin α3
por: Florio, Tyler J., et al.
Publicado: (2022)

A plausible identifiable model of the canonical NF-κB signaling pathway
por: Jaruszewicz-Błońska, Joanna, et al.
Publicado: (2023)

The Involvement of Canonical NFκB Pathway in Megakaryocyte Differentiation Induction by Nanocurcumin
por: Mortazavi Farsani, Seyedeh Sahar, et al.
Publicado: (2023)

Control of RelB during dendritic cell activation integrates canonical and non-canonical NF-κB pathways
por: Shih, Vincent F.-S., et al.
Publicado: (2012)

Let-7g suppresses both canonical and non-canonical NF-κB pathways in macrophages leading to anti-atherosclerosis
por: Wang, Yung-Song, et al.
Publicado: (2017)

Addressing Reported Pro-Apoptotic Functions of NF-κB: Targeted Inhibition of Canonical NF-κB Enhances the Apoptotic Effects of Doxorubicin
por: Bednarski, Brian K., et al.
Publicado: (2009)

Attenuation of canonical NF‐κB signaling maintains function and stability of human Treg
por: Ziegler, Liesa S., et al.
Publicado: (2020)

Renovación de la vivienda : objetivos y estrategia
por: Pepper, Simon 1941-
Publicado: (1975)

MALT1-Dependent Cleavage of HOIL1 Modulates Canonical NF-κB Signaling and Inflammatory Responsiveness
por: Fung, Shan-Yu, et al.
Publicado: (2021)

Telomere length predicts for outcome to FCR chemotherapy in CLL
por: Norris, Kevin, et al.
Publicado: (2019)

NF-κB Inducing Kinase, a Central Signaling Component of the Non-Canonical Pathway of NF-κB, Contributes to Ovarian Cancer Progression
por: Uno, Masaya, et al.
Publicado: (2014)

TWEAK favors phosphate-induced calcification of vascular smooth muscle cells through canonical and non-canonical activation of NFκB
por: Hénaut, L, et al.
Publicado: (2016)

Circulating Tfh1 (cTfh1) cell numbers and PD1 expression are elevated in low-grade B-cell non-Hodgkin’s lymphoma and cTfh gene expression is perturbed in marginal zone lymphoma
por: Byford, Elliot T., et al.
Publicado: (2018)

Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo
por: Nixon, Christopher C., et al.
Publicado: (2020)

A role for NRAGE in NF-κB activation through the non-canonical BMP pathway
por: Matluk, Nicholas, et al.
Publicado: (2010)

Constitutively Active Canonical NF-κB Pathway Induces Severe Bone Loss in Mice
por: Otero, Jesse E., et al.
Publicado: (2012)

Non-canonical Wnt4 prevents skeletal aging and inflammation by inhibiting NF-κB
por: Yu, Bo, et al.
Publicado: (2014)

Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?
por: Noort, Ae R, et al.
Publicado: (2015)

Intestinal non-canonical NFκB signaling shapes the local and systemic immune response
por: Ramakrishnan, Sadeesh K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2dr256qfbco9rehn1mpv7emeb7